Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136157395> ?p ?o ?g. }
- W3136157395 endingPage "155487" @default.
- W3136157395 startingPage "155487" @default.
- W3136157395 abstract "Advanced breast cancer frequently metastasizes to the skeleton causing major mobility issues and hazards to quality of life. To manage osteolytic bone metastasis, bone-modifying agents and chemotherapy are recommended as the standard of care. Here, we investigated serologic biomarkers that might be associated with prognosis in breast cancer patients treated with zoledronic acid (ZA) and taxane-based chemotherapy. We collected serum samples from breast cancer patients with bone metastasis who received taxane plus ZA as palliative treatment. Fourteen biomarkers of angiogenesis, immunogenicity, and apoptosis were assessed, and the correlation between serum cytokine levels and patient's prognosis was statistically analyzed. Sixty-six patients were enrolled, and samples from 40 patients were analyzed after laboratory quality control. Patients with low baseline PDGF-AA, high IFN-γ, low MCP-2, low TGF-β1, and low TNF-α were significantly associated with longer progression-free survival (PFS). Decreasing VEGF and TNF-α and increasing FGF-2 and PDGF-AA in the early treatment phase indicated longer PFS. In univariate and multivariate analyses, low TGF-β1 and TNF-α and high IFN-γ at baseline were associated with a significantly low hazard ratio for disease progression. Further, we designed a risk score with TGF-β1, TNF-α, and IFN-γ levels, which could prognosticate patients for PFS. In conclusion, serum cytokine level, such as TGF-β1, TNF-α, and IFN-γ, could be a potential prognostic biomarker for breast cancer patients with bone metastasis treated with ZA and taxane-based chemotherapy." @default.
- W3136157395 created "2021-03-29" @default.
- W3136157395 creator A5003510838 @default.
- W3136157395 creator A5003556979 @default.
- W3136157395 creator A5007089296 @default.
- W3136157395 creator A5021046796 @default.
- W3136157395 creator A5021861062 @default.
- W3136157395 creator A5035331177 @default.
- W3136157395 creator A5038041478 @default.
- W3136157395 creator A5038481896 @default.
- W3136157395 creator A5039816597 @default.
- W3136157395 creator A5042276732 @default.
- W3136157395 creator A5042529157 @default.
- W3136157395 creator A5049348377 @default.
- W3136157395 creator A5049872669 @default.
- W3136157395 creator A5050867707 @default.
- W3136157395 creator A5051992009 @default.
- W3136157395 creator A5053501652 @default.
- W3136157395 creator A5063462114 @default.
- W3136157395 creator A5070418550 @default.
- W3136157395 creator A5077563153 @default.
- W3136157395 creator A5078559857 @default.
- W3136157395 date "2021-06-01" @default.
- W3136157395 modified "2023-09-25" @default.
- W3136157395 title "Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)" @default.
- W3136157395 cites W1532384917 @default.
- W3136157395 cites W1985504213 @default.
- W3136157395 cites W1986632581 @default.
- W3136157395 cites W1993151604 @default.
- W3136157395 cites W2000894286 @default.
- W3136157395 cites W2006471464 @default.
- W3136157395 cites W2014584180 @default.
- W3136157395 cites W2029353393 @default.
- W3136157395 cites W2029868005 @default.
- W3136157395 cites W2033882650 @default.
- W3136157395 cites W2045031638 @default.
- W3136157395 cites W2045093534 @default.
- W3136157395 cites W2063992586 @default.
- W3136157395 cites W2077073060 @default.
- W3136157395 cites W2083290361 @default.
- W3136157395 cites W2092621634 @default.
- W3136157395 cites W2104607769 @default.
- W3136157395 cites W2112660458 @default.
- W3136157395 cites W2115189949 @default.
- W3136157395 cites W2125252957 @default.
- W3136157395 cites W2131862721 @default.
- W3136157395 cites W2140421126 @default.
- W3136157395 cites W2142234592 @default.
- W3136157395 cites W2144737008 @default.
- W3136157395 cites W2148695112 @default.
- W3136157395 cites W2165011173 @default.
- W3136157395 cites W2316096113 @default.
- W3136157395 cites W2326149331 @default.
- W3136157395 cites W2741552886 @default.
- W3136157395 cites W2918178824 @default.
- W3136157395 cites W2924044764 @default.
- W3136157395 doi "https://doi.org/10.1016/j.cyto.2021.155487" @default.
- W3136157395 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33770643" @default.
- W3136157395 hasPublicationYear "2021" @default.
- W3136157395 type Work @default.
- W3136157395 sameAs 3136157395 @default.
- W3136157395 citedByCount "5" @default.
- W3136157395 countsByYear W31361573952022 @default.
- W3136157395 countsByYear W31361573952023 @default.
- W3136157395 crossrefType "journal-article" @default.
- W3136157395 hasAuthorship W3136157395A5003510838 @default.
- W3136157395 hasAuthorship W3136157395A5003556979 @default.
- W3136157395 hasAuthorship W3136157395A5007089296 @default.
- W3136157395 hasAuthorship W3136157395A5021046796 @default.
- W3136157395 hasAuthorship W3136157395A5021861062 @default.
- W3136157395 hasAuthorship W3136157395A5035331177 @default.
- W3136157395 hasAuthorship W3136157395A5038041478 @default.
- W3136157395 hasAuthorship W3136157395A5038481896 @default.
- W3136157395 hasAuthorship W3136157395A5039816597 @default.
- W3136157395 hasAuthorship W3136157395A5042276732 @default.
- W3136157395 hasAuthorship W3136157395A5042529157 @default.
- W3136157395 hasAuthorship W3136157395A5049348377 @default.
- W3136157395 hasAuthorship W3136157395A5049872669 @default.
- W3136157395 hasAuthorship W3136157395A5050867707 @default.
- W3136157395 hasAuthorship W3136157395A5051992009 @default.
- W3136157395 hasAuthorship W3136157395A5053501652 @default.
- W3136157395 hasAuthorship W3136157395A5063462114 @default.
- W3136157395 hasAuthorship W3136157395A5070418550 @default.
- W3136157395 hasAuthorship W3136157395A5077563153 @default.
- W3136157395 hasAuthorship W3136157395A5078559857 @default.
- W3136157395 hasConcept C121608353 @default.
- W3136157395 hasConcept C126322002 @default.
- W3136157395 hasConcept C143998085 @default.
- W3136157395 hasConcept C207103383 @default.
- W3136157395 hasConcept C2776326535 @default.
- W3136157395 hasConcept C2776694085 @default.
- W3136157395 hasConcept C2777511904 @default.
- W3136157395 hasConcept C2777783956 @default.
- W3136157395 hasConcept C2779013556 @default.
- W3136157395 hasConcept C2781190966 @default.
- W3136157395 hasConcept C44249647 @default.
- W3136157395 hasConcept C530470458 @default.
- W3136157395 hasConcept C71924100 @default.